 |
市場調査レポート
商品コード
1171018
医薬品溶出試験サービスの世界市場－規模・シェア・動向分析：方法別（in vitro、in vivo）、剤形別（カプセル、錠剤）、溶出装置別（バスケット、パドル）、地域別、セグメント予測（2023年～2030年）Pharmaceutical Dissolution Testing Services Market Size, Share & Trends Analysis Report By Method (In Vitro, In Vivo), By Dosage Form (Capsules, Tablets), By Dissolution Apparatus (Basket, Paddle), By Region, And Segment Forecasts, 2023 - 2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| 医薬品溶出試験サービスの世界市場－規模・シェア・動向分析：方法別（in vitro、in vivo）、剤形別（カプセル、錠剤）、溶出装置別（バスケット、パドル）、地域別、セグメント予測（2023年～2030年） |
|
出版日: 2022年11月17日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
世界の医薬品溶出試験サービスの市場規模は、2023年から2030年までに8.0%のCAGRで成長し、2030年に12億米ドルに達すると予測されています。
医薬品開発プロセスの向上、技術の進歩の増加、高品質な製品の必要性に対する意識の高まりは、市場の成長を促進しています。
当レポートでは、世界の医薬品溶出試験サービス市場について調査しており、市場展望、市場分析、競合情勢など、包括的な情報を提供しています。
目次
第1章 調査手法と範囲
- 市場セグメンテーションと範囲
- セグメントの範囲
- 地域範囲
- 調査手法
- 情報調達
- 購入したデータベース
- GVRの内部データベース
- 2次情報
- 1次調査
- 1次調査の詳細
- 情報またはデータ分析
- データ分析モデル
- 市場の策定と検証
- モデルの詳細
- コモディティフロー分析
- アプローチ：商品フローアプローチ
- コモディティフロー分析
- 調査の仮定
- 2次情報リスト
- 略語リスト
- 目的
第2章 エグゼクティブサマリー
- 市場の展望
- セグメントの展望
- 競合の洞察
第3章 医薬品溶解試験サービス市場の変数、動向、および範囲
- 市場系列の展望
- 親市場の展望
- アンシラリー市場の展望
- 浸透と成長の展望のマッピング
- 市場力学
- 市場促進要因分析
- 研究開発活動の増加
- 慢性疾患や感染症の負担増による医薬品の溶出試験需要の後押し
- ジェネリック医薬品の使用の増加
- 市場抑制要因分析
- 方法の検証のための労力の増加
- 市場促進要因分析
- 医薬品溶出試験サービス：市場分析ツール
- 業界分析：ポーターのファイブフォース分析
- PESTEL分析
- 主要取引と戦略的提携
- COVID-19の影響分析
第4章 医薬品溶解試験サービス市場：セグメント分析（100万米ドル）（2018年～2030年）：方法別
- 定義と範囲
- 方法の市場シェア分析（2022年および2030年）
- in vitro
- in vivo
第5章 医薬品溶解試験サービス市場：セグメント分析（100万米ドル）（2018年～2030年）：剤形別
- 定義と範囲
- 剤形の市場シェア分析（2022年および2030年）
- カプセル
- 錠剤
- その他
第6章 医薬品溶解試験サービス市場：セグメント分析（100万米ドル）（2018年～2030年）： 溶出装置別
- 定義と範囲
- 溶出装置の市場シェア分析（2022年および2030年）
- バスケット
- パドル
- その他
第7章 医薬品溶解試験サービス市場：セグメント分析（100万米ドル）（2018年～2030年）：地域別
- 定義と範囲
- 地域の市場シェア分析（2022年および2030年）
- 北米
- 米国
- カナダ
- 欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- アジア太平洋地域
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- 中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- 北米
第8章 医薬品溶解試験サービス市場：競合分析
- 企業プロファイル
- Intertek Group Plc
- Avivia BV
- Almac Group
- Agilent Technologies, Inc.
- Catalent, Inc.
- Thermofisher Scientific Inc.
- Charles River Laboratories
- Cambrex
- Boston Analytical
- SOTAX
- SGS SA
- AMRI
- Pace Analytical Life Sciences
図表
List of Tables
- Table 1 List of secondary sources
- Table 2 List of Abbreviations
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market summary, 2022
- Fig. 5 Market trends & outlook
- Fig. 6 Market segmentation & scope
- Fig. 7 Market driver relevance analysis (Current & future impact)
- Fig. 8 Market restraint relevance analysis (Current & future impact)
- Fig. 9 Penetration & growth prospect mapping
- Fig. 10 SWOT Analysis, By Factor (political & legal, economic and technological)
- Fig. 11 Porter's Five Forces Analysis
- Fig. 12 Pharmaceutical Dissolution Testing Services market: Key takeaways, by method (USD Million)
- Fig. 13 In vitro market revenue estimates and forecast 2018 - 2030 (USD Million)
- Fig. 14 In vivo market revenue estimates and forecast 2018 - 2030 (USD Million)
- Fig. 15 Pharmaceutical Dissolution Testing Services market: Dosage form movement analysis, 2021 & 2030 (USD Million)
- Fig. 16 Capsule market revenue estimates and forecast 2018 - 2030 (USD Million)
- Fig. 17 Tablets market revenue estimates and forecast 2018 - 2030 (USD Million)
- Fig. 18 Others market revenue estimates and forecast 2018 - 2030 (USD Million)
- Fig. 19 Regional marketplace: Key takeaways (USD Million)
- Fig. 20 Regional outlook, 2022 & 2030 (USD Million)
- Fig. 21 North America Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 22 U.S. Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 23 Canada Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 24 Europe Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 25 U.K. Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 26 Germany Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 27 France Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 28 Italy Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 29 Spain Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 30 Asia Pacific Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 31 China Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 32 Japan Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 33 India Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 34 South Korea Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 35 Australia Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 36 Latin America Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 37 Brazil Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 38 Mexico Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 39 Argentina Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 40 MEA Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 41 South Africa Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 42 Saudi Arabia Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 43 UAE Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-003-0
Pharmaceutical Dissolution Testing Services Market Growth & Trends:
The global pharmaceutical dissolution testing services market size is expected to reach USD 1.2 billion by 2030, registering a CAGR of 8.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to increase primarily as a result of the rising drug development process, increasing technological advancements, rising awareness about the need for high-quality products, and the production of numerous medications for various chronic diseases that require dissolution testing. The COVID-19 pandemic has significantly impacted the global industry. Pharmaceutical firms, biotech firms, and other end-user demands were primarily served during the crisis by developing coronavirus prevention drugs.
Since the end of 2019, these organizations have been actively working toward the development of medications that can be used as a treatment for COVID-19 patients who have only minor symptoms. And these drug developments require dissolution testing at each stage to access safety, stability, and efficacy, thus contributing to industry growth. For the physical assessment of solid dosage forms, such as tablets, capsules, ointments, and creams, dissolution testing is required. The simplest type of testing measures the solubility or rate of dissolving a medication tablet. Dissolution testing can be performed to assess the release rates of a drug material under various situations and to provide details regarding the effectiveness of in vivo performance in Absorption, Distribution, Metabolism, And Excretion (ADME) and bioavailability studies.
Dissolution testing provides information on how quickly or slowly certain drugs are absorbed into various body parts and, subsequently, how much they dissolve after administration. This enables businesses to assess whether a drug will function effectively after it enters a patient's system and whether any negative effects brought on by slower absorption rates would occur. Pharmaceutical dissolution testing requires specialized staff to run the assays and prepare regulatory filings. This factor has greatly increased the demand for professional teams to handle pharmaceutical dissolution testing, which is predicted to have a favorable effect on the industry.
Pharmaceutical Dissolution Testing Services Market Report Highlights:
- The in vitro method segment accounted for the largest revenue share in 2022
- The tablets dosage form segment accounted for the largest share and is anticipated to grow at the fastest CAGR during the forecast period
- Tablets have high physical and chemical stability and the amount of drug delivered to the body can be controlled
- Based on dissolution apparatus, the paddle segment dominated the industry in 2022 as it can cover a range of oral dosage forms
- North America dominated the industry in 2022 owing to rising investments by public firms in research and their state-of-the-art research infrastructure
Table of Content
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Segment Scope
- 1.1.2 Regional Scope
- 1.1.3 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach: Commodity Flow Approach
- 1.6.1 Commodity Flow Analysis
- 1.7 Research Assumptions
- 1.8 List of Secondary Sources
- 1.9 List of Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.10.3 Objective 3
- 1.10.4 Objective 4
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
Chapter 3 Pharmaceutical Dissolution Testing Services Market Variables, Trends, and Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration and Growth Prospect Mapping
- 3.3 Market Dynamics
- 3.3.1 Market Drivers Analysis
- 3.3.1.1 Increasing R&D activities
- 3.3.1.2 Rising burden of chronic and infectious diseases supporting demand for dissolution testing of drugs
- 3.3.1.3 Rising use of generic drugs
- 3.3.2 Market Restraint Analysis
- 3.3.2.1 Increased effort for method validation
- 3.3.1 Market Drivers Analysis
- 3.4 Pharmaceutical Dissolution Testing Services: Market Analysis Tools
- 3.4.1 Industry Analysis: Porter's Five Forces
- 3.4.2 PESTEL Analysis
- 3.4.3 Major Deals And Strategic Alliances
- 3.4.4 COVID- 19 Impact Analysis
Chapter 4 Pharmaceutical Dissolution Testing Services Market: Segment Analysis, By Method, 2018 - 2030 (USD Million)
- 4.1 Definition and Scope
- 4.2 Method Market Share Analyses, 2022 & 2030
- 4.2.1 In-vitro
- 4.2.1.1 In-vitro market, 2018 - 2030 (USD Million)
- 4.2.2 In-vivo
- 4.2.2.1 In-vivo market, 2018 - 2030 (USD Million)
- 4.2.1 In-vitro
Chapter 5 Pharmaceutical Dissolution Testing Services Market: Segment Analysis, By Dosage Form, 2018 - 2030 (USD Million)
- 5.1 Definition and Scope
- 5.2 Dosage Form Market Share Analysis, 2022 & 2030
- 5.2.1 Capsules
- 5.2.1.1 Capsules market, 2018 - 2030 (USD Million)
- 5.2.2 Tablets
- 5.2.2.1 Tablets market, 2018 - 2030 (USD Million)
- 5.2.3 Others
- 5.2.3.1 Others market, 2018 - 2030 (USD Million)
- 5.2.1 Capsules
Chapter 6 Pharmaceutical Dissolution Testing Services Market: Segment Analysis, By Dissolution Apparatus, 2018 - 2030 (USD Million)
- 6.1 Definition and Scope
- 6.2 Dosage Form Market Share Analysis, 2022 & 2030
- 6.2.1 Basket
- 6.2.1.1 Basket market, 2018 - 2030 (USD Million)
- 6.2.2 Paddle
- 6.2.2.1 Paddle market, 2018 - 2030 (USD Million)
- 6.2.3 Others
- 6.2.3.1 Others market, 2018 - 2030 (USD Million)
- 6.2.1 Basket
Chapter 7 Pharmaceutical Dissolution Testing Services Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
- 7.1 Definition & Scope
- 7.2 Regional Market Share Analysis, 2022 & 2030
- 7.2.1 North America
- 7.2.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
- 7.2.1.2 U.S.
- 7.2.1.2.1 U.S. pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.1.3 Canada
- 7.2.1.2.1 Canada pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.2 Europe
- 7.2.2.1 Europe pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.2.2 U.K.
- 7.2.2.2.1 U.K. pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.2.3 Germany
- 7.2.2.3.1 Germany pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.2.4 Spain
- 7.2.2.4.1 Spain pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.2.5 France
- 7.2.2.5.1 France pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.2.6 Italy
- 7.2.2.6.1 Italy pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.3 Asia Pacific
- 7.2.3.1 Asia Pacific pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.3.2 Japan
- 7.2.3.2.1 Japan pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.3.3 China
- 7.2.3.3.1 China pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.3.4 India
- 7.2.3.4.1 India pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.3.5 South Korea
- 7.2.3.5.1 South Korea pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.3.7 Australia
- 7.2.3.7.1 Australia pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.4 Latin America
- 7.2.4.1 Latin America pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.4.2 Brazil
- 7.2.4.2.1 Brazil pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.4.3 Mexico
- 7.2.4.3.1 Mexico pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.4.4 Argentina
- 7.2.4.4.1 Argentina pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.5 MEA
- 7.2.5.1 MEA pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.5.2 South Africa
- 7.2.5.2.1 South Africa pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.5.3 Saudi Arabia
- 7.2.5.3.1 Saudi Arabia pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.5.4 UAE
- 7.2.5.4.1 UAE pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
- 7.2.1 North America
Chapter 8 Pharmaceutical Dissolution Testing Services Market: Competitive Analysis
- 8.1 Company Profiles
- 8.1.1 Intertek Group Plc
- 8.1.1.1 Company overview
- 8.1.1.2 Financial performance
- 8.1.1.3 Product benchmarking
- 8.1.1.4 Strategic initiatives
- 8.1.2 Avivia BV
- 8.1.2.1 Company overview
- 8.1.2.2 Financial performance
- 8.1.2.3 Product benchmarking
- 8.1.2.4 Strategic initiatives
- 8.1.3 Almac Group
- 8.1.3.1 Company overview
- 8.1.3.2 Financial performance
- 8.1.3.3 Product benchmarking
- 8.1.3.4 Strategic initiatives
- 8.1.4 Agilent Technologies, Inc.
- 8.1.4.1 Company overview
- 8.1.4.2 Financial performance
- 8.1.4.3 Product benchmarking
- 8.1.4.4 Strategic initiatives
- 8.1.5 Catalent, Inc.
- 8.1.5.1 Company overview
- 8.1.5.2 Financial performance
- 8.1.5.3 Product benchmarking
- 8.1.5.4 Strategic initiatives
- 8.1.6 Thermofisher Scientific Inc.
- 8.1.6.1 Company overview
- 8.1.6.2 Financial performance
- 8.1.6.3 Product benchmarking
- 8.1.6.4 Strategic initiatives
- 8.1.7 Charles River Laboratories
- 8.1.7.1 Company overview
- 8.1.7.2 Financial performance
- 8.1.7.3 Product benchmarking
- 8.1.7.4 Strategic initiatives
- 8.1.8 Cambrex
- 8.1.8.1 Company overview
- 8.1.8.2 Financial performance
- 8.1.8.3 Product benchmarking
- 8.1.8.4 Strategic initiatives
- 8.1.9 Boston Analytical
- 8.1.9.1 Company overview
- 8.1.9.2 Financial performance
- 8.1.9.3 Product benchmarking
- 8.1.9.4 Strategic initiatives
- 8.1.10 SOTAX
- 8.1.10.1 Company overview
- 8.1.10.2 Financial performance
- 8.1.10.3 Product benchmarking
- 8.1.10.4 Strategic initiatives
- 8.1.11 SGS SA
- 8.1.11.1 Company overview
- 8.1.11.2 Financial performance
- 8.1.11.3 Product benchmarking
- 8.1.11.4 Strategic initiatives
- 8.1.12 AMRI
- 8.1.12.1 Company overview
- 8.1.12.2 Financial performance
- 8.1.12.3 Product benchmarking
- 8.1.12.4 Strategic initiatives
- 8.1.13 Pace Analytical Life Sciences
- 8.1.13.1 Company overview
- 8.1.13.2 Financial performance
- 8.1.13.3 Product benchmarking
- 8.1.13.4 Strategic initiative
- 8.1.1 Intertek Group Plc
